Neuland Laboratories Reports Mixed Financial Results for December Quarter 2024
Neuland Laboratories has released its financial results for the quarter ending December 2024, showcasing a blend of achievements and challenges. The company reported its highest earnings per share in five quarters, while also experiencing declines in profit before tax and profit after tax, reflecting a nuanced performance in the pharmaceuticals sector.
Neuland Laboratories has recently reported its financial results for the quarter ending December 2024, revealing a complex picture of performance within the pharmaceuticals and drugs sector. The company has experienced a notable adjustment in its evaluation, with its score shifting to -6 from -13 over the past three months.On a positive note, Neuland Laboratories achieved its highest earnings per share (EPS) in the last five quarters, reaching Rs 78.75, indicating an increase in profitability and enhanced earnings for shareholders. Additionally, the company's debtors turnover ratio has improved, now standing at 5.00 times, reflecting a more efficient process in settling debts.
Conversely, the financial results also highlight challenges for Neuland Laboratories. The profit before tax (PBT) has shown a decline, recorded at Rs 68.07 crore, which is a decrease of 19.6% compared to the average PBT of the previous four quarters. Similarly, profit after tax (PAT) has also fallen to Rs 57.24 crore, down 13.3% from the average PAT of the prior quarters.
Overall, Neuland Laboratories' recent financial results illustrate a mix of strengths and weaknesses, prompting a revision in its score.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
